Research.Patient.info
Solid Tumors Harboring NTRK Fusion research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
This study is testing a new cancer medicine called larotrectinib for children with certain types of tumours. It looks at how safe the drug is, how it works in the body, and how well it helps treat cancers that have a specific gene change (NTRK fusion).
United States · Australia · Canada - ongoing, recruitingTherapeutic exploratory (Phase II)
(20289) A Phase 2 Basket Study of the Oral TRK Inhibitor larotrectinib in Subjects with NTRK Fusion-Positive Tumors
This study is testing a new medicine, larotrectinib, for adult patients with certain types of cancer that have a specific genetic change called an 'NTRK fusion'. Doctors want to see how well the medicine shrinks these tumours and if it's safe.
Spain · Germany · Denmark